SAN DIEGO, CA--(Marketwire - Nov 28, 2012) - SpectraScience, Inc. (
The Company's Chief Financial Officer, Jim Dorst, will join Mr. Oliver and both will be available during the conference to discuss recent developments at SpectraScience with conference attendees. Mr. Oliver will further discuss the status of the Company's distribution partnership with PENTAX Europe, GmbH, the cost reduction benefits of using light-based diagnostics to supplant physical biopsy and the emerging light-based detection and diagnostic market as a whole.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate result. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.